Original Research

Published on 09 Mar 2023

Survival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world study

in Thoracic Oncology

Chien-Hung Gow
Min-Shu Hsieh
Yi-Lin Chen
Yi-Nan Liu
Shang-Gin Wu
Jin-Yuan Shih

Frontiers in Oncology

doi 10.3389/fonc.2023.1113696

3,207 views
2 citations

Study Protocol

Published on 09 Mar 2023

Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)

in Thoracic Oncology

Marinda Meertens
M. Benthe Muntinghe-Wagenaar
Barend J. Sikkema
Marta Lopez-Yurda
Valesca P. Retèl
Marthe S. Paats
Rob Ter Heine
Ed Schuuring
Wim Timens
Daan J. Touw

Frontiers in Oncology

doi 10.3389/fonc.2023.1136221

5,820 views
3 citations

Review

Published on 08 Mar 2023

Incorporating risk preferences of patients in the valuation of immune checkpoint inhibitors for non-small cell lung cancer

in Thoracic Oncology

Remziye Zaim
W. Ken Redekop
Carin A. Uyl-de Groot

Frontiers in Oncology

doi 10.3389/fonc.2023.1027659

1,389 views
1 citation

Brief Research Report

Published on 08 Mar 2023

Prognostic significance of eighth edition TNM stage criteria in combined small-cell lung cancer

in Thoracic Oncology

Ziran Zhao
Yibo Gao
Fengwei Tan
Qi Xue
Shugeng Gao
Jie He

Frontiers in Oncology

doi 10.3389/fonc.2023.1018288

1,672 views

Review

Published on 07 Mar 2023

The role of artificial intelligence based on PET/CT radiomics in NSCLC: Disease management, opportunities, and challenges

in Thoracic Oncology

Qiuyuan Hu
Ke Li
Conghui Yang
Yue Wang
Rong Huang
Mingqiu Gu
Yuqiang Xiao
Yunchao Huang
Long Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1133164

3,282 views
6 citations

Original Research

Published on 07 Mar 2023

A comprehensive nomogram combining CT-based radiomics with clinical features for differentiation of benign and malignant lung subcentimeter solid nodules

in Thoracic Oncology

Chengyu Chen
Qun Geng
Gesheng Song
Qian Zhang
Youruo Wang
Dongfeng Sun
Qingshi Zeng
Zhengjun Dai
Gongchao Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1066360

1,384 views
6 citations

Original Research

Published on 06 Mar 2023

Prognostic and immunological characteristics of CDK1 in lung adenocarcinoma: A systematic analysis

in Thoracic Oncology

Qingwu Du
Wenting Liu
Ting Mei
Jingya Wang
Tingting Qin
Dingzhi Huang

Frontiers in Oncology

doi 10.3389/fonc.2023.1128443

2,472 views
4 citations

Original Research

Published on 03 Mar 2023

Association between anlotinib trough plasma concentration and treatment outcomes in advanced non-small-cell lung cancer

in Thoracic Oncology

Ling Chen
Hong Jiang
Jun-jie Rao
Liu-sheng Wang
Wei Yan
Jian Ye
Jiang Lou

Frontiers in Oncology

doi 10.3389/fonc.2023.1146362

1,210 views

Original Research

Published on 28 Feb 2023

Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma

in Thoracic Oncology

Po-Hsin Lee
Chun-Ju Chiang
Jeng-Sen Tseng
Zhe-Rong Zheng
Kun-Chieh Chen
Cheng-Hsiang Chu
Yen-Hsiang Huang
Kuo-Hsuan Hsu
Wen-Chung Lee
Tsung-Ying Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1096683

1,428 views
3 citations

Case Report

Published on 24 Feb 2023

Case report: Pulmonary synovial sarcoma in a long-term survivor of childhood Hodgkin lymphoma

in Thoracic Oncology

Konstantin Shilo
Peter J. Kneuertz
David Liebner
Wei Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1096160

440 views
1 citation

Original Research

Published on 24 Feb 2023

Development and validation of a mutation-based model to predict immunotherapeutic efficacy in NSCLC

in Thoracic Oncology

Ping He
Jie Liu
Qingyuan Xu
Huaijun Ma
Beifang Niu
Gang Huang
Wei Wu

Frontiers in Oncology

doi 10.3389/fonc.2023.1089179

1,784 views

Original Research

Published on 23 Feb 2023

CNS efficacy of afatinib as first-line treatment in advanced non-small cell lung cancer patients with EGFR mutations

in Thoracic Oncology

Liping Kang
Jianliang Mai
Weiting Liang
Qihua Zou
Caiwen Huang
Yongbin Lin
Ying Liang

Frontiers in Oncology

doi 10.3389/fonc.2023.1094195

2,388 views
3 citations

Original Research

Published on 23 Feb 2023

Artificial-intelligence-based computed tomography histogram analysis predicting tumor invasiveness of lung adenocarcinomas manifesting as radiological part-solid nodules

in Thoracic Oncology

Jian Gao
Qingyi Qi
Hao Li
Zhenfan Wang
Zewen Sun
Sida Cheng
Jie Yu
Yaqi Zeng
Nan Hong
Dawei Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1096453

2,121 views
5 citations

Original Research

Published on 23 Feb 2023

Clinical factors influencing long-term survival in a real-life cohort of early stage non-small-cell lung cancer patients in Spain

in Thoracic Oncology

Maria Torrente
Pedro A. Sousa
Gracinda R. Guerreiro
Fabio Franco
Roberto Hernández
Consuelo Parejo
Alexandre Sousa
José Luis Campo-Cañaveral
João Pimentão
Mariano Provencio

Frontiers in Oncology

doi 10.3389/fonc.2023.1074337

1,677 views
1 citation

Original Research

Published on 23 Feb 2023

Nomogram prediction model of postoperative pneumonia in patients with lung cancer: A retrospective cohort study

in Thoracic Oncology

Fan Jin
Wei Liu
Xi Qiao
Jingpu Shi
Rui Xin
Hui-Qun Jia

Frontiers in Oncology

doi 10.3389/fonc.2023.1114302

1,372 views

Original Research

Published on 22 Feb 2023

Multivariate analysis of prognostic factors in patients with lung cancer

in Thoracic Oncology

Changjiang Liu
Minting Ma
Xuetao Zhou
Zefeng Zhang
Yang Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1022862

1,585 views
2 citations

Navigation group

Articles

Survival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world study

Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)

Incorporating risk preferences of patients in the valuation of immune checkpoint inhibitors for non-small cell lung cancer

Prognostic significance of eighth edition TNM stage criteria in combined small-cell lung cancer

The role of artificial intelligence based on PET/CT radiomics in NSCLC: Disease management, opportunities, and challenges

A comprehensive nomogram combining CT-based radiomics with clinical features for differentiation of benign and malignant lung subcentimeter solid nodules

Prognostic and immunological characteristics of CDK1 in lung adenocarcinoma: A systematic analysis

Association between anlotinib trough plasma concentration and treatment outcomes in advanced non-small-cell lung cancer

Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma

Case report: Pulmonary synovial sarcoma in a long-term survivor of childhood Hodgkin lymphoma

Development and validation of a mutation-based model to predict immunotherapeutic efficacy in NSCLC

CNS efficacy of afatinib as first-line treatment in advanced non-small cell lung cancer patients with EGFR mutations

Artificial-intelligence-based computed tomography histogram analysis predicting tumor invasiveness of lung adenocarcinomas manifesting as radiological part-solid nodules

Clinical factors influencing long-term survival in a real-life cohort of early stage non-small-cell lung cancer patients in Spain

Nomogram prediction model of postoperative pneumonia in patients with lung cancer: A retrospective cohort study

Multivariate analysis of prognostic factors in patients with lung cancer